news

Congratulations to NanoRay Biotech for its anticancer therapy approved by the US FDA for Clinical Trial

NanoRay Biotech’s Auger Molecular Therapy (AMT), FDA-approved for Clinical Trial, targets cancer cells via intratumoral iodine injection, using the
September 29, 2022

BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs

Shanghai, August 8, 2022 – BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International
August 08, 2022

Bioduro-Sundia’s Wuxi GMP Manufacturing Facility Granted the Drug Manufacturing License

Shanghai, July 1st, 2022 – BioDuro-Sundia, a leading drug discovery, development and commercial services organization backed by Advent International
July 01, 2022

BioDuro-Sundia Appoints Kent Payne CEO

BioDuro-Sundia names Kent Payne, PhD, as CEO, aiming for expanded growth and innovation in drug discovery, development, and commercial services globally
February 14, 2022

Congratulations to Dr. Junbo Wang & his team for winning the Best Collaboration Award of Luye Pharma in 2021

Dr. Junbo Wang & his team from BioDuro-Sundia’s Chemistry department won the ” Best Collaboration Award ” issued by Luye Pharma, in recognition of their ...
January 20, 2022

BioDuro-Sundia CEO gave a keynote speech at the 2022 J.P. Morgan Healthcare Conference!

Dr. Kent Payne, CEO of BioDuro-Sundia, highlighted the company's comprehensive CRDMO services at the 2022 J.P. Morgan Healthcare Conference in San Francisco
January 14, 2022

BioDuro-Sundia Receives 2021 Best Partner Award from Haihe Biopharma Drug Discovery Department

BioDuro-Sundia, awarded 2021 Best Partner by Haihe Biopharma, expands drug discovery with 1700+ staff across global R&D centers for comprehensive client support
January 06, 2022

BioDuro-Sundia Acquires 2nd US-based Commercial Drug Product Manufacturing Facility along with Commercial Supply Agreement

BioDuro-Sundia to acquire a fully-operational 45,000 ft2 commercial oral solid dose drug product manufacturing facility in Irvine, California | BioDuro-Sundia
November 08, 2021
Total 93 12345678...1112
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all